-
Dr. Ana Aparicio Answers Questions About Prostate Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Ana Aparicio, of The University of Texas MD Anderson Cancer Center, answers questions about prostate cancer…
-
Dr. Nabil F. Saba Answers Questions About Head and Neck Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Nabil F. Saba, of Winship Cancer Institute at Emory University, answers questions about immunotherapy for head…
-
Dr. Van Morris Answers Questions About Colorectal Cancer and Immunotherapy at the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Van Morris, of MD Anderson Cancer Center, answers questions about immunotherapy clinical trials from the 2021…
-
Dr. Hearn Jay Cho Answers Questions About Blood Cancer And Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Hearn Jay Cho, of Mount Sinai Tisch Cancer Institute, answers questions about blood cancer and immunotherapy…
-
Dr. Kunle Odunsi Answers Questions About Immunotherapy Clinical Trials After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi, of the University of Chicago Medicine Comprehensive Cancer Center, answers questions about immunotherapy clinical…
-
Dr. Ellen Puré Answers Questions About The Basics of Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Ellen Puré, of the University of Pennsylvania, answers questions about the basics of immunotherapy after the…
-
Sarcoma Awareness Month: 2021 Immunotherapy Research Updates
This July for Sarcoma Awareness Month, we look at new research, new treatments, and how we’re working…
-
Impacto de la pandemia de COVID-19 en los ensayos clínicos oncológicos: análisis de seguimiento a un año
Un nuevo informe del CRI destaca la repercusión de la pandemia de COVID-19 en los ensayos clínicos…
-
12 Challenges for 2021: Fundraising Ideas for Every Month of the Year
Commit to change in 2021 and advance cancer immunotherapy research. Get fundraising ideas for every month of…
